Calibrate Telemedicine Blueprint

Shaan discusses Calibrate, a telemedicine platform focused on weight loss prescriptions that has achieved significant growth by facilitating access to weight loss drugs like Ozempic/Semaglutide. This creates an opportunity for similar telemedicine platforms.

Key Points:

• Business Model:

  • Connect patients with doctors online for weight loss drug prescriptions
  • Focus on GLP-1 medications (Ozempic, Wegovy, etc.)
  • Provide telemedicine consultations and ongoing prescription management

• Market Validation (Calibrate's Performance):

  • Reached $450 million valuation
  • Scaled to $50 million run rate in less than 24 months
  • Projecting $60 million by end of year
  • Forecasting $140 million by next year

• Revenue Drivers:

  • Monthly prescription costs around $500
  • High customer retention due to ongoing prescription needs
  • Growing market awareness through celebrity usage and media coverage

• Additional Revenue Opportunities:

  • Content creation around drug reviews and scientific summaries
  • SEO-optimized educational content
  • Affiliate marketing ($3,000-$10,000 per lead potential)
  • Facebook groups and community building
  • YouTube content focused on reviews and experiences

• Market Timing:

  • Growing Google search trends
  • Increasing mainstream awareness
  • Celebrity endorsements driving demand
  • Current supply constraints creating opportunity